©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2012; 18(14): 1565-1572
Published online Apr 14, 2012. doi: 10.3748/wjg.v18.i14.1565
Published online Apr 14, 2012. doi: 10.3748/wjg.v18.i14.1565
Table 1 Staging of pancreatic cancer
| Stage | TNM classification | Clinical classification | 5-year percent survival (mo) |
| Stage 0 | TisN0M0 | Resectable | |
| StageIA | T1N0M0 | Initial | 31.4 |
| StageIB | T2N0M0 | 27.2 | |
| Stage IIA | T3N0M0 | 15.7 | |
| Stage IIB | TXN1M0 | Locally advanced | 7.7 |
| Stage III | T4NXM0 | 6.8 | |
| Stage IV | TXNXM1 | Metastatic | 2.8 |
- Citation: Herreros-Villanueva M, Hijona E, Cosme A, Bujanda L. Adjuvant and neoadjuvant treatment in pancreatic cancer. World J Gastroenterol 2012; 18(14): 1565-1572
- URL: https://www.wjgnet.com/1007-9327/full/v18/i14/1565.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i14.1565